Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Study of Tetanus Antibody Protective Efficacy in Healthy Populations in Beijing

NCT07724379 is registered in ClinicalTrials.gov with Peking University First Hospital as lead sponsor.

NCT NCT07724379
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07724379 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Study of Tetanus Antibody Protective Efficacy in Healthy Populations in Beijing
Lead sponsor
Peking University First Hospital
Phase
Observational
Overall status
Completed
Start date
May 4, 2025
Completion date
May 15, 2026
Enrollment
2,009 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

tetanus